Micromet Inc (MITI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micromet Inc (MITI)

MITI 0.0446

+6.4%

Dec 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	8/3/2006 3:14:58 PM
	Read Replies (1) of 196

For some reason, Loonie Bros. has MicroMet as an underweight (I don't have access to their reasoning). Seems as though the chief near term risk would be the MT201 PII data in breast and prostate cancer coming by year end. PI results from MT103 would seem less of a risk, given that PII is where most drugs go to die. So, anybody looked at the trial design for red flags or . . . ? Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next